US appeals court sides with Sun Pharma in Lipitor antitrust case
In an intimation to the stock exchange, the Mumbai-based drugmaker said, “the court of Appeals has affirmed the order of the District Court granting summary judgment in its entirety in…
NPPA fixes retail prices for 41 drug combinations, including empagliflozin
The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 41 drug combinations, including 18 variants of the off-patent diabetes drug empagliflozin, originally developed by German pharmaceutical company…
Atorvastatin banned by the UP State Medical Supplies Corporation
The UP state government banned to use substandard cardiac medicine “Atorvastatin” and recalls from govt hospitals. Medicine was supplied to over 160 government hospitals in Uttar Pradesh, failed on quality…
